Ignite Creation Date:
2024-05-05 @ 4:56 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00344942
Status:
TERMINATED
Last Update Posted:
2009-12-07
First Post:
2006-06-26
Brief Title:
Efficacy and Safety Study of Nasacort in Chronic Non Allergic and Non Infectious Rhinitis in Adults
Sponsor:
Sanofi
Organization:
Sanofi
Study Overview
Official Title:
A Randomised Double-blind French Multi-centre Study to Evaluate the Efficacy and Tolerance in Comparison With Placebo of Nasacort in Chronic Non Allergic and Non Infectious Rhinitis in Adults
Status:
TERMINATED
Status Verified Date:
2009-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
patients recruitment too difficult
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
RhiCNANI
Brief Summary:
To demonstrate the superiority of the clinical efficacy of 12 weeks treatment with Nasacort versus placebo in adult patients presenting with Chronic Non Allergic and Non Infectious Rhinitis
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| EudraCT 2006-000059-16 | None | None | None |